…Teva Highly selective β₁-blocker The most β₁-selective of the routinely used beta-blockers, with documented mortality benefit in heart failure from CIBIS-II…
12 träffar
…Teva Highly selective β₁-blocker The most β₁-selective of the routinely used beta-blockers, with documented mortality benefit in heart failure from CIBIS-II…
…the loop of Henle. The dose–response relationship is a threshold curve, not a line: below the threshold nothing happens, and in renal failure the…
…20–30 minutes after the infusion ends, it is useful in patients where beta-blockade is desirable but risky — impending heart failure, obstructive lung disease…
…and heart failure resembles that of selective COX-2 inhibitors and is seen already at doses below 100 mg/day and with short treatment duration…
…2 diabetes in EMPA-REG OUTCOME, reduced heart failure events regardless of ejection fraction in EMPEROR-Reduced and EMPEROR-Preserved, and slowed renal function decline…
…no clinically significant negative inotropic effect and can therefore be used in heart failure with reduced ejection fraction when blood pressure or angina requires it…
…symptomatic patient with HFrEF who remains above 70 beats per minute despite maximally tolerated beta-blockade, where SHIFT demonstrated reduced risk of heart failure hospitalisation.
…be neutralised completely with protamine within minutes. This is why unfractionated heparin is the first choice in severe renal failure, in the bleeding-prone patient…
…ACE inhibitor Prodrug hydrolysed to enalaprilat. Reduces mortality in heart failure with reduced ejection fraction — the effect is dose-dependent, and underdosing is more often…
…determines its use. Amoxicillin is therefore not first-line for uncomplicated acute otitis media — that role belongs to phenoxymethylpenicillin — but for treatment failure, recurrent otitis…
…in heart failure (CHARM), and the first choice when an ACE inhibitor must be switched due to cough. The target dose in heart failure is…
…extends well beyond the diabetes indication. DAPA-HF demonstrated reduced cardiovascular death and worsening heart failure with reduced ejection fraction, DELIVER showed equivalent benefit with…